ScRNA-seq and bulk RNA-seq reveal the characteristics of NK cell and establish a risk signature in bladder cancer

Bladder cancer poses a significant risk of recurrence and progression to intramuscular disease, also known as non-muscle invasive bladder cancer (NMIBC). Immunotherapy has emerged as a pioneering strategy for managing non-muscle invasive bladder cancer (NMIBC). However, there exist variations in the resistance patterns of immune checkpoint inhibitors (ICIs) and the corresponding patient response, thereby necessitating further investigation into novel therapeutic interventions.Several research studies have indicated that the focused metabolism of sulphur dioxide could potentially serve as a substitute for existing approaches to treating bladder cancer. The research was centred on the examination of genetic variations of genes responsible for the metabolism of sulphur dioxide (DRGs) that are linked to bladder cancer. The research revealed that out of the 412 samples analysed, 136 exhibited mutations in DRGs, indicating a mutation rate of 33.01%.The research additionally discovered that duplications or deletions of genomic segments, known as copy number variants (CNV), are prevalent in bladder carcinoma, particularly in relation to dorsal root ganglia (DRGs).The investigation additionally examined the impact of genetic variations on messenger RNA (mRNA) expression. The results indicated a positive correlation between the level of expression of specific genes in bladder cancer tissue and the variation in replicating numbers. The investigation also recognised two types of sulphur dioxide metabolism that are dispersed, and are linked with distinct gene expression patterns and characteristics of immune cell infiltration. The investigation enhanced the examination of genes with differential expression and revealed that the bladder cancer tumour microenvironment was linked to the metabolism of sulphur dioxide, which resulted in varying prognostic outcomes. The investigation additionally formulated a prognostic instrument utilising clinical parameters and risk assessments. The potential of the predictive signature to correlate with the metabolism of sulphur dioxide has implications for the characterization of a patient's immune landscape and the prediction of their prognosis. However, additional research is required to address various concerns, such as the validation of models' accuracy and efficacy, as well as the undertaking of more prospective and fundamental investigations.